Crispr Therapeutics Ag · NASDAQ:CRSP

Behbahani Ali reported 2 trades in Crispr Therapeutics Ag shares (Form 4)

Traded Aug 6, 2025 · Filed Sep 21, 2026

On Aug 6, 2025, Behbahani Ali (Director) reported 2 trades in Crispr Therapeutics Ag shares, leaving 29 shares. Filed Sep 21, 2026 (Form 4).

Shares
75 shares
Holding after
29 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2025Common SharesOther60316Direct
Aug 6, 2025Common SharesOther1529Indirect

Source

View original at SEC

Related